Koerber Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.75 Cr
as on 30-07-2024
- Paid Up Capital ₹ 1.61 Cr
as on 30-07-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 41.75%
(FY 2023)
- Profit -27.75%
(FY 2023)
- Ebitda -27.96%
(FY 2023)
- Net Worth 55.01%
(FY 2023)
- Total Assets 52.13%
(FY 2023)
About Koerber Pharma
The Corporate was formerly known as Koerber Medipak Systems India Private Limited. The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 1.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Vedak, Jorn Gosse, and Jens Woehlbier serve as directors at the Company.
- CIN/LLPIN
U74999MH2018FTC307130
- Company No.
307130
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
26 Mar 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Navi Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Koerber Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Vedak  | Managing Director | 10-Sep-2019 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jens Woehlbier  | Director | 24-Jan-2020 | Current |
| Jorn Gosse | Director | 24-Jan-2020 | Current |
Financial Performance of Koerber Pharma.
Koerber Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 41.75% increase. The company also saw a substantial fall in profitability, with a 27.75% decrease in profit. The company's net worth Soared by an impressive increase of 55.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Koerber Pharma?
In 2023, Koerber Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Koerber Pharma?
Koerber Pharma has a workforce of 107 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Koerber Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Koerber Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
